INTERNATIONAL PATENT: ADVERUM BIOTECHNOLOGIES, INC. FILES APPLICATION FOR "ANTI-AAV2.7M8 ANTIBODIES AND METHODS OF USE THEREOF"

GENEVA, April 30 -- ADVERUM BIOTECHNOLOGIES, INC. (100 Cardinal WayRedwood City, CA 94063) filed a patent application (PCT/US2024/052048) for "ANTI-AAV2.7M8 ANTIBODIES AND METHODS OF USE THEREOF" on Oct 18, 2024. With publication no. WO/2025/085799, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): STRINGS-UFOMBAH, Vanessa (c/o Adverum Biotechnologies, Inc.100 Cardinal WayRedwood City, CA 94063)

Abstract: The present disclosure is directed to antibodies that specifically bind to the AAV2.7m8 capsid protein as antigen, an...